Bimekizumab in hidradenitis suppurativa: a valid and effective emerging treatment
Elisa Molinelli, Daisy Gambini, Andrea Maurizi, Edoardo De Simoni, Claudia Sapigni, Sara Belleggia, Giulio Rizzetto, Annamaria Offidani, Oriana Simonetti
Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease in which many inflammatory mediators such as interleukin-17 are involved in the pathophysiology. We describe a rapid improvement in the skin lesions of HS in patients with psoriasis treated with bimekizumab.
Topics & Concepts
Hidradenitis suppurativaMedicinePsoriasisDermatologyPathophysiologyDiseasePathologyHidradenitis Suppurativa and TreatmentsColorectal and Anal CarcinomasChemotherapy-related skin toxicity